Cite
Olgasi C, Borsotti C, Merlin S, et al. Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device. Mol Ther Methods Clin Dev. 2021;23:551-566doi: 10.1016/j.omtm.2021.10.015.
Olgasi, C., Borsotti, C., Merlin, S., Bergmann, T., Bittorf, P., Adewoye, A. B., Wragg, N., Patterson, K., Calabria, A., Benedicenti, F., Cucci, A., Borchiellini, A., Pollio, B., Montini, E., Mazzuca, D. M., Zierau, M., Stolzing, A., Toleikis, P. M., Braspenning, J., & Follenzi, A. (2021). Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device. Molecular therapy. Methods & clinical development, 23551-566. https://doi.org/10.1016/j.omtm.2021.10.015
Olgasi, Cristina, et al. "Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device." Molecular therapy. Methods & clinical development vol. 23 (2021): 551-566. doi: https://doi.org/10.1016/j.omtm.2021.10.015
Olgasi C, Borsotti C, Merlin S, Bergmann T, Bittorf P, Adewoye AB, Wragg N, Patterson K, Calabria A, Benedicenti F, Cucci A, Borchiellini A, Pollio B, Montini E, Mazzuca DM, Zierau M, Stolzing A, Toleikis PM, Braspenning J, Follenzi A. Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device. Mol Ther Methods Clin Dev. 2021 Nov 03;23:551-566. doi: 10.1016/j.omtm.2021.10.015. eCollection 2021 Dec 10. PMID: 34853801; PMCID: PMC8606349.
Copy
Download .nbib